Medical technology giant Medtronic will purchase ... of our innovative pipeline products, and will expand access to our therapies and offerings to the sizeable heart failure population." ...

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

Another heart product in the Medtronic line is the cryoballoon, which freezes heart tissue responsible for irregular beats. The devices are sold to hospitals, enabling thousands of patients to be ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Sales were higher at the company's cardiovascular ... and new product innovation is fueling diversified growth across key health tech market." Medtronic changed its full-year outlook for organic ...

Medtronic's business is diversified. The company boasts dozens of devices across four main segments: Medical surgical, neuroscience, cardiovascular ... be a dire need for products that help ...

Cardiovascular ... said Gary Corona, Medtronic’s interim chief financial officer. “We’re raising our guidance today as we ...

The company operates in four business segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. Medtronic sells products in many end markets in these segments. It is usually the ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

The company said it was expecting steady growth as it introduces new products and continues ... as diabetes and devices for heart disease-focused surgeries. Medtronic also remains "on the hunt ...